Skip to main content
Premium Trial:

Request an Annual Quote

Marligen Gets $100,000 from ASM Resources

NEW YORK, April 19 (GenomeWeb News) - Marligen Biosciences has received $100,000 from ASM Resources, ASMR said today.

 

Marligen, based in Ijamsville, Md., offers products and services for gene expression analysis, genotyping, and nucleic acid purification. The company will use the funding for ongoing operations, sales, and marketing.

 

ASMR, based in Washington, DC, is a for-profit venture capital firm owned by the American Society for Microbiology. It supports early-stage biotechnology companies.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.